Biopharmaceutical company Bristol-Myers Squibb has chosen Veeva Vault RIM solutions to manage registration tracking and submission archiving globally.
Vault RIM is part of Veeva Vault, the first cloud-based regulated content management platform and suite of applications designed for life sciences.
The Veeva Vault Registrations provides a single global destination for planning, tracking and reporting on product registrations and health authority correspondence to streamline registration management and speed responses to health authorities.
This next-generation regulatory solution supports IDMP compliance with an IDMP-based data model, an open integration interface, and the ability to generate IDMP messages.
Using Vault SubmissionsArchive, life sciences companies will be able to respond faster to business changes or health authority requests with easy and global access to submissions and regulatory correspondence.
Vault SubmissionsArchive stores content in a compliant repository that simplifies administration of security policies and permissions.
It allows remote team members to access authorised submissions from anywhere in the world.
Veeva Vault RIM director John Lawrie said: "Life sciences companies struggle to manage product submissions and registration information around the world.
"Veeva understands the breadth of this challenge and has introduced a unified solution that helps harmonise global operations and provides the visibility organisations need to manage their product portfolio more effectively."
The Veeva Vault family of applications span clinical, quality, commercial, medical, and regulatory to ensure one trusted source for content and data across the enterprise, the company said.